Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients-Reference-Cited by-同舟云学术

Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients

Published:2019-06-10 Issue:8 Volume:97 Page:1155-1167
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Heilmann Thorsten,Vondung Florian,Borzikowsky Christoph,Szymczak Silke,Krüger Sandra,Alkatout Ibrahim,Wenners Antonia,Bauer Maret,Klapper Wolfram,Röcken Christoph,Maass Nicolai,von Karstedt Silvia,Schem Christian,Trauzold Anna

Funder

Deutsche Forschungsgemeinschaft

Deutsche Krebshilfe

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00109-019-01805-w.pdf

Reference47 articles.

1. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A et al (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104:155–162

2. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J 16:5386–5397

3. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T et al (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157–163

4. Philipp S, Sosna J, Plenge J, Kalthoff H, Adam D (2015) Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis. Cell Commun Signal 13:25

5. Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF, Goodwin RG, Smith CA (1997) Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 186:1165–1170

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum TRAIL predicts severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study;Internal and Emergency Medicine;2022-10-14

2. Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells;Frontiers in Cell and Developmental Biology;2022-09-09

3. Proteasome inhibition triggers the formation of TRAIL receptor 2 platforms for caspase-8 activation that accumulate in the cytosol;Cell Death & Differentiation;2021-08-05

4. TRAIL-receptor 2—a novel negative regulator of p53;Cell Death & Disease;2021-07-31

5. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer;BMC Cancer;2021-01-18